Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients

Clinical trial NCT00610194 · COMPLETED

Trial details

NCT number: NCT00610194
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2007-11-28
Primary completion: 2010-11-24
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.